Citius Oncology, Inc. CTOR Adjustments To Additional Paid In Capital Other
Adjustments To Additional Paid In Capital Other at other companies
Other financials
Where this comes from
Reported directly by Citius Oncology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AdjustmentsToAdditionalPaidInCapitalOther.
The official record: Citius Oncology, Inc.’s 10-K, filed December 23, 2025, on SEC EDGAR. View the filing →
Ask your AI about Citius Oncology, Inc.'s adjustments to additional paid in capital other.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Citius Oncology, Inc.'s adjustments to additional paid in capital other?
- Citius Oncology, Inc. (CTOR) reported adjustments to additional paid in capital other of $9.25M in Q3 2024.
- What does adjustments to additional paid in capital other mean?
- Captures miscellaneous adjustments made to the additional paid-in capital account that do not fall under standard share-based compensation or specific issuance categories. These adjustments often relate to equity-linked transactions, tax effects on equity, or other non-operating capital changes. Monitoring these helps investors understand non-recurring shifts in the company's equity base.